Quarterly report pursuant to Section 13 or 15(d)

Stockholders' equity (Tables)

v3.21.2
Stockholders' equity (Tables)
3 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Schedule of warrants or rights
                 
     Common Stock
from Warrants
     Weighted-
average
Exercise Price
(per share)
 
Outstanding at July 1, 2021
     107,095      $ 10.50  
    
 
 
    
 
 
 
Outstanding and exercisable at September 30, 2021
     107,095      $ 10.50  
Schedule of equity awards
                                 
     Stock
Options
     Weighted-
average
Exercise
Price
     Weighted-
average
Remaining
Contractual Term
     Aggregate
Intrinsic Value
 
Outstanding at June 30, 2021
     702,064      $ 7.16        8.07 years      $ —    
Outstanding at September 30, 2021
     702,064        7.16        7.82 years     
$
—    
Exercisable at September 30, 2021
     54,158      $ 47.90        1.84 years      $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of share-basedcompensation expense
                 
    
Three Months Ended

September 30,
 
(US$’000)
  
2021
    
2020
 
Research and development
   $ 81      $ 9  
General and administrative
     190        29  
    
 
 
    
 
 
 
Total share-based compensation expense
   $ 271      $ 38